Grapheal develops and produces rapid, sensitive biosensors built on proprietary electrochemical nanodevices and carbon nanostructures. Its PFAST product line comprises graphene sensors designed for ultra-trace, real-time detection of per- and polyfluoroalkyl substances (PFAS). The company's devices are engineered for high-sensitivity detection of chemical and biochemical markers and to interface readily with mobile technologies such as smartphones. The recent €2.5M EIC grant is intended to support advancement of the PFAST sensors. Grapheal positions itself in biomedical and chemical detection applications through its deep-tech sensor platform. The company is based in Grenoble, France.

Total raised

$5M

Funding rounds

5

Latest round

Grant

Latest activity

Jun 2026